Related Experiment Video
Updated: May 2, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
13.2K
FAS system deregulation in T-cell lymphoblastic lymphoma
M Villa-Morales1, M A Cobos1, E González-Gugel2
11] Centro de Biología Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain [2] Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain [3] Instituto de Investigación Sanitario Fundación Jiménez Díaz, ISCIII, Madrid, Spain.
Cell Death & Disease
|March 8, 2014
Summary
Resistance to FAS-mediated apoptosis is crucial for tumor formation. This study reveals widespread FAS pathway impairment in T-cell lymphoblastic lymphomas (T-LBLs), impacting prognosis and therapy.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Acquisition of resistance to FAS-mediated apoptosis is linked to tumor formation.
- While FAS mutations are common in hematological malignancies, their role in precursor T-cell lymphoblastic lymphomas (T-LBLs) is understudied.
- Existing data on related leukemias suggest mechanisms beyond FAS mutations can impair FAS signaling and confer chemoresistance.
Purpose of the Study:
- To investigate the status of FAS-mediated apoptotic signaling in human T-LBL samples.
- To identify the specific mechanisms responsible for FAS pathway deregulation in T-LBLs.
Main Methods:
- Analysis of FAS signaling pathway components in 26 T-LBL patient samples.
- Assessment of FAS mutations, FAS expression levels, and alterations in other pathway members.
Main Results:
- The FAS system is significantly impaired in 57.7% of T-LBL cases studied.
- Identified mechanisms include FAS downregulation, deregulation of other pathway members, and FAS mutations.
- Evidence suggests a cumulative effect of multiple alterations contributes to FAS/FASLG system deregulation in T-LBL.
Conclusions:
- Defective FAS signaling in T-LBLs can promote resistance to apoptosis.
- Understanding the comprehensive alterations in the FAS signaling pathway is essential for accurate diagnosis, prognosis, and effective anticancer therapy in T-LBL.
